Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
Jonsson Comprehensive Cancer Center National Cancer Institute (NCI) |
---|---|
Information provided by: | National Cancer Institute (NCI) |
ClinicalTrials.gov Identifier: | NCT00335751 |
RATIONALE: Diagnostic procedures, such as PET scan and CT scan, may help doctors determine the extent of cancer and predict a patient's response to treatment and help plan the best treatment.
PURPOSE: This clinical trial is studying how well PET scan combined with CT scan evaluates treatment response in patients undergoing treatment for bone cancer or soft tissue sarcoma.
Condition | Intervention |
---|---|
Sarcoma |
Procedure: computed tomography Procedure: positron emission tomography Procedure: radionuclide imaging Radiation: fludeoxyglucose F 18 |
Study Type: | Interventional |
Study Design: | Diagnostic |
Official Title: | Glucose Metabolic Response by PET/CT to Sarcoma Treatments |
Estimated Enrollment: | 120 |
Study Start Date: | January 2006 |
OBJECTIVES:
OUTLINE: This is a prospective, pilot study. Patients are stratified according to disease (high-grade soft tissue sarcoma vs low-grade soft tissue sarcoma vs osteosarcoma).
Patients undergo fludeoxyglucose ^18F positron-emission tomography (FDG-PET)/CT scanning at baseline and then within 2 weeks and 12 weeks after the start of treatment (total of 3 scans).
PROJECTED ACCRUAL: A total of 120 patients will be accrued for this study.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
DISEASE CHARACTERISTICS:
PATIENT CHARACTERISTICS:
PRIOR CONCURRENT THERAPY:
United States, California | |
Jonsson Comprehensive Cancer Center at UCLA | Recruiting |
Los Angeles, California, United States, 90095-1781 | |
Contact: Clinical Trials Office - Jonsson Comprehensive Cancer Center a 888-798-0719 |
Study Chair: | Johannes Czernin, MD | Jonsson Comprehensive Cancer Center |
Study ID Numbers: | CDR0000480348, UCLA-0508095-01 |
Study First Received: | June 8, 2006 |
Last Updated: | February 6, 2009 |
ClinicalTrials.gov Identifier: | NCT00335751 History of Changes |
Health Authority: | Unspecified |
recurrent adult soft tissue sarcoma stage I adult soft tissue sarcoma localized osteosarcoma metastatic osteosarcoma |
recurrent osteosarcoma stage II adult soft tissue sarcoma stage III adult soft tissue sarcoma stage IV adult soft tissue sarcoma |
Neoplasms, Connective and Soft Tissue Soft Tissue Sarcomas Malignant Mesenchymal Tumor Bone Neoplasms |
Sarcoma Osteogenic Sarcoma Osteosarcoma Recurrence |
Neoplasms, Connective and Soft Tissue Neoplasms Neoplasms by Histologic Type Sarcoma |